# Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers

> **NCT04337437** · PHASE1 · UNKNOWN · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** Genakumab
- **DRUG:** Placebo for this trial

## Key facts

- **NCT ID:** NCT04337437
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-22
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337437, "Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04337437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*